Latest Breaking News On - Ahmedabad based zydus - Page 1 : comparemela.com

Drugmakers Zydus, MSN join hands to make, market generic cancer drug Cabozantinib for U S

Drugmakers Zydus, MSN join hands to make, market generic cancer drug Cabozantinib for U S
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshZydus lifesciencesSharvil patelDrugmakers zydus lifesciencesCabozantinib tabletsAbbreviated new drug applicationAhmedabad based zydusZydus lifesciences global

Swiss and Indian Pharma Giants Locked in Big War; Land at DCGI Door Over Breast Cancer Drug | Exclusive

Swiss pharmaceutical firm Roche has sounded alarm against clinical trials conducted by Zydus Lifesciences on its biologic drug Perjeta, a widely-used breast cancer treatment. The Swiss company has filed a complaint against the Indian drug maker over alleged critical gaps in the clinical trial of a drug originally developed by Roche

New delhiPerjeta pertuzumabAmitav banerjeeZydus lifesciencesRajiv gandhi cancer instituteArmed forces medical collegeResearch centreIndia institute of medical sciencesCentre trialNational institute of virologyDr dy patil medical collegeAhmedabad based zydusDrug controller generalNovel biologicsClinical trial registryAll india institute

DCGI grants emergency use authorisation to Corbevax for 12-18 year age group

This approval for Corbevax is likely to speed up the ongoing vaccination drive for children between 15 and 18 years of age, and also for those between 12 and 14 years of age. However, the approval is subject to certain conditions.

New delhiZydus cadillaHealth ministryExpert committee onDrugs controller generalSubject expert committeeAhmedabad based zydusAngiotensin convertingCovid 19Covid 19 vaccineCorona vaccinesCovid vaccines for childrenCovid 19 vaccines for childrenCovid 19 vaccines

COVID-19 vaccination for children to begin soon: Here s who will be prioritized

COVID-19 vaccination for children to begin soon: Here s who will be prioritized
dnaindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dnaindia.com Daily Mail and Mail on Sunday newspapers.

Zydus cadilaNational immunization technical advisory groupSerum institute of indiaDrugs controller generalAhmedabad based zydusEmergency use authorisationSerum institute

Who will be prioritised once COVID-19 vaccination drive for children commences?

The Drugs Controller General of India (DCGI) has approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above. The vaccine is currently waiting to be introduced in the national vaccination programme.

New delhiZydus cadila zycoZydus cadilaNational immunization technical advisory groupSerum institute of indiaDrugs controller generalAhmedabad based zydusEmergency use authorisationSerum instituteCovid 19Covid 19 vaccineCoronavirus vaccineCovid 19 vaccine for kidsVaccine for kidsCorona vaccine for kidsYdus cadilas dna vaccine